BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2000
View Archived Issues
Bausch & Lomb reports progress with breakthrough treatment for serious eye diseases
Read More
ImmunoGen and Genentech sign TAP license agreement
Read More
Multiple positive cardiac effects established for Novogen's NV-04
Read More
Orphan drug status awarded to arsenic trioxide for multiple myeloma
Read More
CDD and ICRT to collaborate on anticancer drug development
Read More
Oxford BioMedica acquires development rights to nitroreductase genes
Read More
Special access program approved for Visudyne in Canada
Read More
Optison litigation ends, new agreements concerning ultrasound products reached
Read More
Novavax enters licensing option for metronidazole analogues
Read More
Multikine shows promising efficacy and safety in phase II trial
Read More
Orion updates product pipeline
Read More
Biomira makes progress with therapeutic cancer vaccines
Read More
Oxigene makes solid progress during Q1 2000
Read More
Clasp-1: a novel transmembrane protein localized at the interface of T- and B-cell clusters
Read More
Specially designed contrast agents for tumors reported by Schering
Read More
Chiron and collaborators develop potential new treatments for meningitis and sepsis
Read More
Multitarget antiinflammatory agents designed at Merckle
Read More
HMW endostatins for treatment and diagnosis of tumors disclosed by Haemopep
Read More
New NPS compounds interact with a novel site on receptor-operated Ca2+ channels
Read More
Antitumor agents from American Cyanamid act by inhibiting PTKs
Read More
Kinase inhibitors under evaluation at major German pharmaceutical laboratory
Read More
Eisai investigates selective RARalpha agonists for dermatologic, immunologic disorders
Read More
Patients with ovarian cancer sought for phase III trial
Read More
New VLA-4 antagonist designed at Celltech is a potent, orally active antiasthmatic agent
Read More
Multiple mechanisms of action endow new compound with potent activity in models of COPD and asthma
Read More
Investigational anticoagulant H-376/95/melagatran given wide coverage at recent congress
Read More
Atlantic to begin clinical trials of synthetic derivative of marijuana
Read More
Modafinil proves useful for improving multiple sclerosis-related fatigue
Read More